Phase II Clinical Study of JTE-052A - Dose finding study in patients with atopic dermatitis
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2016
At a glance
- Drugs JTE 052 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Japan Tobacco
- 15 Jun 2016 New trial record
- 25 May 2016 Status changed from active, no longer recruiting to completed.
- 19 Feb 2016 Status changed from recruiting to active, no longer recruiting.